Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.28 - $2.4 $57,630 - $108,057
-45,024 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.19 - $6.09 $45,639 - $126,915
20,840 Added 86.17%
45,024 $99,000
Q4 2021

Feb 14, 2022

BUY
$5.81 - $14.39 $27,707 - $68,625
4,769 Added 24.56%
24,184 $148,000
Q3 2021

Nov 15, 2021

BUY
$11.55 - $20.3 $65,973 - $115,953
5,712 Added 41.68%
19,415 $269,000
Q2 2021

Aug 17, 2021

SELL
$17.9 - $23.29 $44,803 - $58,294
-2,503 Reduced 15.44%
13,703 $276,000
Q1 2021

May 17, 2021

BUY
$13.71 - $30.64 $32,602 - $72,861
2,378 Added 17.2%
16,206 $348,000
Q4 2020

Feb 16, 2021

BUY
$9.31 - $14.0 $128,738 - $193,592
13,828 New
13,828 $194,000

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.